MORRISVILLE — A clinical research organization in Morrisville has raised $5.7 million in a private equity offering, according to a Securities and Exchange Commission filing.

Clinipace Worldwide Inc.  raised the offering from 13 investors, according to the filing.

It last raised money in November 2017, when it raised $3 million.


Founded in 2003, Clinipace Clinical Research was originally built as a software company that has since grown into a global, full-service contract research organization.

The company aims to bring new therapies and medications to market, impact the lives of patients around the world and provide up-and-coming levels of partnership and efficiency not seen in traditional clinical research organizations.

Providing services in clinical development, regulatory affairs and clinical analysis, the organization’s geographic coverage includes North America, Latin America, Asia-Pacific and Eastern and Western Europe.

Clinipace CEO Jason Montelone joined the team in 2017 after co-founder Jeff Williams resigned as CEO. Montelone has more than 20 years of health care and life science industry experience.

Private firms such as Clinipace relying on the Rule 506 exemption do not have to register their offering of securities with the SEC, but they must file what’s known as a Form D electronically with the SEC after they first sell their securities.

The form can be found here.

This story is from the North Carolina Business News Wire, a service of the UNC-Chapel Hill School of Media and Journalism